Prolific Machines, the biotechnology company advancing biologics development and manufacturing through integrated optogenetics-enabled solutions delivering breakthrough yields, superior on-target quality, and precise process control, announced the initial closing of its $50M Series B2 financing led by Atoms & Bits, a growth-stage fund, and Nant Capital, the investment organization which is part of a portfolio of private and public companies in health and life sciences founded by Patrick Soon-Shiong, M.D. This brings the company's total funding to over $100 million.